ORCID as entered in ROS

Select Publications
2024, 'Emerging Dilemmas in the Age of Resistance: The Case of Sexually Transmitted Infections', Qualitative Health Research, http://dx.doi.org/10.1177/10497323241302668
,2024, 'Factors associated with hepatitis B knowledge among people of Vietnamese ethnicity in Australia', Psychology Health and Medicine, 29, pp. 1536 - 1547, http://dx.doi.org/10.1080/13548506.2024.2350703
,2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895
,2024, 'Normalising sex and resisting shame: young Aboriginal women’s views on sex and relationships in an urban setting in Australia', Journal of Youth Studies, 27, pp. 1460 - 1476, http://dx.doi.org/10.1080/13676261.2023.2225422
,2024, 'The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs', Health Sociology Review, 33, pp. 104 - 118, http://dx.doi.org/10.1080/14461242.2024.2315031
,2024, 'Yarning as a method for building sexual wellbeing among urban Aboriginal young people in Australia', Culture Health and Sexuality, 26, pp. 871 - 886, http://dx.doi.org/10.1080/13691058.2023.2258948
,2023, 'Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study', Implementation Science, 18, http://dx.doi.org/10.1186/s13012-023-01281-4
,2023, 'Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00885-9
,2023, 'Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00844-4
,2023, 'Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob program’s ‘cascade of care’ across nine sites in New South Wales, Australia', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00850-6
,2023, 'Insights from the scale-up and implementation of the Deadly Liver Mob program across nine sites in New South Wales, Australia, according to the RE-AIM framework', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00889-5
,2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', Ssm Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
,2023, 'Socioeconomic consequences of the COVID-19 pandemic for people who use drugs', Australian Journal of Social Issues, 58, pp. 907 - 925, http://dx.doi.org/10.1002/ajs4.289
,2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723
,2023, 'Improving understandings of trauma and alcohol and other drug-related problems: A social research agenda', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104198
,2023, 'Psychosocial stress and methamphetamine use: A mixed-methods study of intersectional stigma and Aboriginal and Torres Strait Islander methamphetamine use', International Journal of Drug Policy, 121, http://dx.doi.org/10.1016/j.drugpo.2023.104189
,2023, 'Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104142
,2023, 'Typology of laws restricting access to methadone treatment in the United States: A latent class analysis', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104141
,2023, 'Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers', Drug and Alcohol Dependence, 249, http://dx.doi.org/10.1016/j.drugalcdep.2023.109953
,2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study', Journal of Substance Use and Addiction Treatment, 150, http://dx.doi.org/10.1016/j.josat.2023.209066
,2023, 'Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia', Qualitative Health Research, 33, pp. 688 - 700, http://dx.doi.org/10.1177/10497323231173788
,2023, 'Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples', Mental Health and Prevention, 30, http://dx.doi.org/10.1016/j.mhp.2023.200267
,2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137
,2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002
,2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998
,2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6
,2023, 'Factors associated with sharing equipment among people who inject drugs: The role of community attachment in harm reduction and health promotion', Drug and Alcohol Review, 42, pp. 561 - 568, http://dx.doi.org/10.1111/dar.13606
,2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959
,2023, 'Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment', Time and Society, 32, pp. 50 - 74, http://dx.doi.org/10.1177/0961463X221128736
,2023, 'Aboriginal young people’s perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative study', Global Public Health, 18, pp. 2196561, http://dx.doi.org/10.1080/17441692.2023.2196561
,2023, 'Child Sexual Abuse, Alcohol and Other Drug use and the Criminal Justice System: The Meanings of Trauma in Survivor Narratives for a National Royal Commission', Qualitative Health Research, 33, pp. 117 - 126, http://dx.doi.org/10.1177/10497323221144923
,2023, 'Economies of resistance', Critical Public Health, 33, pp. 763 - 775, http://dx.doi.org/10.1080/09581596.2023.2271140
,2023, 'People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study', Drug and Alcohol Review, 42, pp. 203 - 212, http://dx.doi.org/10.1111/dar.13531
,2023, 'The impact of sources of stigma on health care avoidance among gay and bisexual men in Australia', AIDS Care Psychological and Socio Medical Aspects of AIDS HIV, 35, pp. 663 - 671, http://dx.doi.org/10.1080/09540121.2022.2057410
,2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925
,2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
,2022, 'A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00658-w
,2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876
,2022, 'Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00619-3
,2022, 'Commentary on the harm reduction reference group of justice health and forensic mental health network and corrective services NSW, Australia', International Journal of Prisoner Health, 18, pp. 394 - 406, http://dx.doi.org/10.1108/IJPH-06-2021-0050
,2022, 'Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions', Viruses, 14, http://dx.doi.org/10.3390/v14112542
,2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246
,2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408
,2022, 'Hepatitis B-related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Health and Social Care in the Community, 30, pp. e5602 - e5611, http://dx.doi.org/10.1111/hsc.13986
,2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828
,2022, 'Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Journal of Viral Hepatitis, 29, pp. 968 - 975, http://dx.doi.org/10.1111/jvh.13736
,2022, 'What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review', Health and Social Care in the Community, 30, pp. e3775 - e3788, http://dx.doi.org/10.1111/hsc.14066
,2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788
,2022, 'Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103771
,2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746
,